Sofie Qiao is the founder of Vivace Therapeutics. Vivace Therapeutics has raised $35M in total funding. Latest round: Series D. Based in San Mateo, CA.
Sofie Qiao, Ph.D., is the President and Chief Executive Officer of Vivace Therapeutics. Vivace Therapeutics is a small molecule discovery and development company based in the San Francisco Bay Area, focusing on first-in-class cancer therapies targeting the Hippo pathway. The company recently closed a $35 million Series D financing round, led by RA Capital Management, with participation from Canaan Partners and Cenova Capital, to support the clinical development of its cancer drug VT3989.
Full founder directory · Investor directory · Company funding database · Fundraising library